Figure 8
Figure 8. Proposed role of TESC/NHE1/pH axis in sorafenib-resistant AML. (A) In sorafenib-resistant AML, TESC was significantly upregulated, leading to increased activity of NHE1, more efflux of H+, and hence higher pHi, increased cellular proliferation and antiapoptosis, reduced intracellular sorafenib level, and unopposed FLT3 activity. The question mark represents a yet to be identified mechanism of NHE1 activity in addition to TESC. (B) With HMA, NHE1 activity was reduced, resulting in lower pHi, inhibition of proliferation and apoptosis induction, increased intracellular sorafenib level, and more FLT3 inhibition. Lower pHi also reduced FLT3 signaling directly.

Proposed role of TESC/NHE1/pH axis in sorafenib-resistant AML. (A) In sorafenib-resistant AML, TESC was significantly upregulated, leading to increased activity of NHE1, more efflux of H+, and hence higher pHi, increased cellular proliferation and antiapoptosis, reduced intracellular sorafenib level, and unopposed FLT3 activity. The question mark represents a yet to be identified mechanism of NHE1 activity in addition to TESC. (B) With HMA, NHE1 activity was reduced, resulting in lower pHi, inhibition of proliferation and apoptosis induction, increased intracellular sorafenib level, and more FLT3 inhibition. Lower pHi also reduced FLT3 signaling directly.

Close Modal

or Create an Account

Close Modal
Close Modal